Skip to main content

Table 6 Healthcare resources and other resources utilization by individuals who reported self-medication with cannabis in an online survey in Quebec from November 2020 to January 2021 (n = 489)

From: A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada

  Gender Age (years) Type of cannabis use Total participants (n = 489) N (%)a
Men Women p-value$ ≤34 >34 p-value$ Medical use only (n = 122) Medical + recreational use (n = 367) p-value$
Treated condition(s) were diagnosed N= 232 N= 234 0.050 N= 248 N= 233 <.0001 N= 120 N= 362 0.0009 N= 482
 Yes, all treated conditions 95 (40.95) 122 (52.14)   86 (34.68) 135 (57.94)   73 (60.83) 149 (41.16)   222 (46.06)
 Yes, but not all treated conditions 85 (36.64) 72 (30.77)   97 (39.11) 67 (28.76)   29 (24.17) 135 (37.29)   164 (34.02)
 No 52 (22.41) 40 (17.09)   65 (26.21) 31 (13.30)   18 (15.00) 78 (21.55)   96 (19.92)
Declaration of cannabis use to healthcare professionalsc N = 191 N = 151 0.1345 N = 170 N = 180 0.0276 N = 90 N = 261 0.034 N= 351
 Yes, always 111 (58.12) 72 (47.68)   78 (45.88) 107 (59.44)   51 (56.67) 135 (51.72)   186 (52.99)
 Yes, sometimes 56 (29.32) 52 (34.44)   65 (38.24) 47 (26.11)   20 (22.22) 92 (35.25)   112 (31.91)
 No 24 (12.57) 27 (17.88)   27 (15.88) 26 (14.44)   19 (21.11) 34 (13.03)   53 (15.10)
Resources consulted for cannabis use N = 235 N = 238   N = 252 N = 236   N = 122 N = 367   N = 489
 Physician 87 (37.02) 51 (21.43) 0.0002 67 (26.59) 75 (31.78) 0.2070 34 (27.87) 109 (29.70) 0.700 143 (29.24)
 Pharmacist 19 (8.09) 17 (7.14) 0.70 21 (8.33) 15 (6.36) 0.4037 9 (7.38) 27 (7.36) 0.99 36 (7.36)
 Legal recreational cannabis store agent 73 (31.06) 102 (42.86) 0.0079 85 (33.72) 95 (40.25) 0.1355 53 (43.44) 127 (34.60) 0.079 180 (36.81)
 Illegal seller 25 (10.64) 18 (7.56) 0.24 27 (10.71) 18 (7.63) 0.2388 6 (4.92) 39 (10.63) 0.059 45 (9.20)
 Agent from a cannabis production company 18 (7.66) 13 (5.46) 0.33 15 (5.95) 17 (7.20) 0.5769 10 (8.20) 22 (5.99) 0.39 32 (6.54)
 Psychologist or psychotherapist 26 (11.06) 15 (6.30) 0.066 25 (9.92) 16 (6.78) 0.2113 9 (7.38) 32 (8.72) 0.64 41 (8.38)
 Naturopath or herborist 9 (3.83) 6 (2.52) 0.42 9 (3.57) 7 (2.97) 0.7075 4 (3.28) 12 (3.27) 0.99 16 (3.27)
 Other resourcesa 31 (13.19) 20 (8.40) 0.093 24 (9.52) 31 (13.14) 0.2074 19 (15.57) 36 (9.81) 0.081 55 (11.25)
 Never consulted 88 (37.45) 98 (41.18) 0.406 108 (42.86) 83 (35.17) 0.0821 39 (31.97) 152 (41.42) 0.064 191 (39.06)
Information sought by consulting a resource (n = 298 as 191 never consulted a resource) N = 147 N = 140   N = 144 N = 153   N = 83 N = 215   N = 298
 Methods of cannabis consumption 28 (19.05) 45 (32.14) 0.011 36 (25.00) 38 (24.84) 0.9740 28 (33.73) 46 (21.40) 0.027 74 (24.83)
 Available varieties and concentrations/potencies of cannabis products 69 (46.94) 85 (60.71) 0.027 78 (54.17) 84 (54.90) 0.8988 47 (56.63) 115(53.49) 0.626 162 (54.36)
 Efficacy of cannabis 78 (53.06) 86 (61.43) 0.152 85 (59.03) 85 (55.56) 0.5455 52 (62.65) 118 (54.88) 0.225 170 (57.05)
 Safety of cannabis/adverse effects 31 (21.09) 24 (17.14) 0.396 35 (24.31) 22 (14.38) 0.0299 17 (20.48) 41 (19.07) 0.783 58 (19.46)
 Safety to combine cannabis with other medication 35 (23.81) 37 (26.43) 0.609 36 (25.00) 40 (26.14) 0.8214 25 (30.12) 51 (23.72) 0.256 76 (25.50)
 Subjective effect of cannabis (‘high’) 33 (22.45) 23 (16.43) 0.198 42 (29.17) 18 (11.76) 0.0002 4 (4.82) 56 (26.05) <0.0001 60 (20.13)
 Otherb 12 (8.16) 5 (3.57) 0.099 12 (8.33) 8 (5.23) 0.2860 4 (4.82) 16 (7.44) 0.417 20 (6.71)
Would like to have access to a healthcare professional regarding medical use of cannabis (n = 343; missing = 14)c
 Yes 146 (79.78) 122 (80.79) 0.82 136 (82.93) 139 (78.09) 0.2602 72 (80.00) 204 (80.63) 0.90 276 (80.47)
  1. Comparisons between groups were made using chi-square tests and p-value calculated. A p-value <0.05 was considered as statistically significant
  2. $See Supplemental Table 1 for pairwise comparisons for categorical variables with a significant global p-value
  3. aOther resources included friends/relative/other patients; Internet (Health Canada documentation, scientific articles, online forums), nurses, social worker, physiotherapist, and nutritionist
  4. bOther included substitution of cannabis with benzodiazepines and antidepressants, information on the medical access process, if their health condition could be treated with cannabis, risk of dependence with cannabis, information on the reimbursement by insurance, information on the endocannabinoid system, what to do in case of intoxication
  5. cThese variables were completed by a subset of the participants (n = 357) as these questions were added to the questionnaire after the start of the survey